Risks and benefits of multiple sclerosis therapies: need for continual assessment?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risks and benefits of multiple sclerosis therapies: need for continual assessment?

Published:2011-06 Issue:3 Volume:24 Page:238-243
ISSN:1350-7540
Container-title:Current Opinion in Neurology
language:en
Short-container-title:

Author:

Kieseier Bernd C,Wiendl Heinz,Hartung Hans-Peter,Leussink Verena-Isabell,Stüve Olaf

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Clinical Neurology,Neurology

Reference37 articles.

1. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis;Rothwell;Br Med J,1997

2. Quality of life in multiple sclerosis: measuring the disease effects more broadly;Nortvedt;Neurology,1999

3. Health problems and health-related quality of life in people with multiple sclerosis;Forbes;Clin Rehabil,2006

4. Quality of life in multiple sclerosis: determinants, measurement, and use in clinical practice;Miller;Curr Neurol Neurosci Rep,2010

5. The impact of fatigue on patients with multiple sclerosis;Fisk;Can J Neurol Sci,1994

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Anti-Inflammatory Effect of Sulforaphane in Mice with Experimental Autoimmune Encephalomyelitis;Journal of Korean Medical Science;2019

2. Brain and Spinal Cord MRI in Multiple Sclerosis: an Update;AKTUEL NEUROL;2018

3. Design, synthesis and evaluation of an anthraquinone derivative conjugated to myelin basic protein immunodominant (MBP85-99) epitope: Towards selective immunosuppression;European Journal of Medicinal Chemistry;2018-01

4. Modulating inflammation and neuroprotection in multiple sclerosis;Journal of Neuroscience Research;2017-06-05

5. Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models;Brain, Behavior, and Immunity;2017-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3